Development of a novel prognostic nomogram for AIDS-associated diffuse large B-cell lymphoma: a retrospective study from northern China
Clinical and Experimental Medicine · 2025
DOI: 10.1007/s10238-025-01586-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Medicine, 2025. Verfasst von Ying Liang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory for HIV/AIDS Research, Clinical and Research Center for Infectious Diseases, Beijing Institute of Hepatology, Beijing Youan Ho…. Hauptthemen laut MEDLINE: Nomograms, Lymphoma, Large B-Cell, Diffuse, Acquired Immunodeficiency Syndrome, Lymphoma, AIDS-Related. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Natural Science Foundation, Beijing research center for respiratory infectious diseases project.
Abstract (Originalsprache)
Despite advancements in antiretroviral therapy, AIDS-related diffuse large B-cell lymphoma (AR-DLBCL) remains a major cause of morbidity and mortality. Compared to non-HIV-infected individuals, AR-DLBCL presents with considerable disease heterogeneity, which impairs the accuracy of current prognostic tools. This study aims to develop a novel prognostic model to enhance risk assessment for AR-DLBCL. We retrospectively analyzed 90 AR-DLBCL cases using univariate and multivariate analyses to identify clinical factors affecting overall survival (OS) and progression-free survival (PFS). A nomogram was created based on independent OS risk factors. The cohort had a median age of 43 years (range: 22-75), with 96.5% male patients. The median follow-up was 30 months (range: 1-139), with 5-year OS and PFS rates of 60.7% and 58.7%, respectively. Key prognostic factors for OS included decreased absolute lymphocyte count (p = 0.002), extranodal involvement (p = 0.005), reduced hemoglobin (Hb) levels (p = 0.004), Epstein-Barr virus (EBV) infection (p = 0.005), and elevated lactate dehydrogenase (LDH) levels (p = 0.018). The nomogram demonstrated robust predictive performance, with a 5-year receiver operating characteristic curve area under the curve of 0.949. Its C-index of 0.849 surpassed the International Prognostic Index (IPI) and age-adjusted IPI (aaIPI), which had C-index of 0.708 and 0.693, respectively. Additionally, the nomogram identified significant OS differences among low risk, intermediate-low risk, intermediate-high risk, and high-risk groups, with 5-year survival rates of 100%, 88%, 56%, and 8%, respectively. The model offers a personalized risk assessment for AR-DLBCL patients, facilitating precise prognosis prediction and informing individualized treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Beijing Key Laboratory for HIV/AIDS Research, Clinical and Research Center for Infectious Diseases, Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
- Department of Pathology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
- Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
- Department of Respiratory and Critical Care Medicine, Beijing Youan Hospital, Capital Medical University, Beijing, China.
- Department of Hematology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China. 15366110086@163.com.
- Beijing Key Laboratory for HIV/AIDS Research, Clinical and Research Center for Infectious Diseases, Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China. gcpdt001@1…
ORCID-Profile: Yulin Zhang
Förderung
- Beijing Natural Science Foundation
- Beijing research center for respiratory infectious diseases project
Zitieren
APA
Liang, Y., Chang, J., Gao, Y., Zhang, L., Chen, X., Zheng, C., Sun, Y., Zhang, X., Guo, C., & Zhang, Y. (2025). Development of a novel prognostic nomogram for AIDS-associated diffuse large B-cell lymphoma: a retrospective study from northern China. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-025-01586-2
Vancouver
Liang Y, Chang J, Gao Y, Zhang L, Chen X, Zheng C, et al. Development of a novel prognostic nomogram for AIDS-associated diffuse large B-cell lymphoma: a retrospective study from northern China. Clinical and Experimental Medicine. 2025. doi:10.1007/s10238-025-01586-2
BibTeX
@article{Liang2025,
author = {Liang, Ying and Chang, Jing and Gao, Yuxue and Zhang, Ling and Chen, Xue and Zheng, Caopei and Sun, Yuqing and Zhang, Xiuqun and Guo, Caiping and Zhang, Yulin},
title = {Development of a novel prognostic nomogram for AIDS-associated diffuse large B-cell lymphoma: a retrospective study from northern China},
journal = {Clinical and Experimental Medicine},
year = {2025},
doi = {10.1007/s10238-025-01586-2}
}
EUVIMED